Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles by BY PAM BELLUCK


A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for the treatment.

Published: December 20, 2021 at 11:25PM

from NYT Health https://ift.tt/3Ejvpoe